• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯妥英钠所致美沙酮戒断反应。

Phenytoin-induced methadone withdrawal.

作者信息

Tong T G, Pond S M, Kreek M J, Jaffery N F, Benowitz N L

出版信息

Ann Intern Med. 1981 Mar;94(3):349-51. doi: 10.7326/0003-4819-94-3-349.

DOI:10.7326/0003-4819-94-3-349
PMID:7224382
Abstract

Methadone-maintained volunteers experienced moderately severe opiate withdrawal symptoms within 3 or 4 days of beginning phenytoin in therapeutic doses. The area under the methadone plasma concentration-time curve decreased while the ratio of the pyrrolidine-to-metabolite excretion in urine to this area increased significantly. This suggests that phenytoin accelerates methadone metabolism. Methadone dosing adjustments should be anticipated when phenytoin is initiated or discontinued in methadone-maintained patients.

摘要

接受美沙酮维持治疗的志愿者在开始服用治疗剂量苯妥英钠后的3至4天内出现了中度严重的阿片类戒断症状。美沙酮血浆浓度-时间曲线下面积减小,而尿液中吡咯烷代谢物排泄量与该面积的比值显著增加。这表明苯妥英钠加速了美沙酮的代谢。在美沙酮维持治疗的患者开始或停用苯妥英钠时,应预计到需要调整美沙酮剂量。

相似文献

1
Phenytoin-induced methadone withdrawal.苯妥英钠所致美沙酮戒断反应。
Ann Intern Med. 1981 Mar;94(3):349-51. doi: 10.7326/0003-4819-94-3-349.
2
[Drug interactions with methadone].[美沙酮的药物相互作用]
Presse Med. 1999 Sep 4;28(25):1381-4.
3
Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.乙酰左旋肉碱在美沙酮戒断综合征疼痛管理中的应用
Clin Neuropharmacol. 2009 Jan-Feb;32(1):35-40. doi: 10.1097/WNF.0B013E31815DD465.
4
The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers.利匹韦林对HIV阴性志愿者体内美沙酮药代动力学的影响。
J Clin Pharmacol. 2014 Feb;54(2):133-40. doi: 10.1002/jcph.222. Epub 2013 Nov 23.
5
Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment.聚乙二醇化干扰素α-2b对美沙酮药代动力学和药效学特性的影响:一项针对接受美沙酮维持治疗的丙型肝炎合并人类免疫缺陷病毒感染患者的前瞻性、非随机、交叉研究。
Clin Ther. 2007 Jan;29(1):131-8. doi: 10.1016/j.clinthera.2007.01.009.
6
Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.美沙酮脱毒期间剂量对阿片类药物戒断症状严重程度的影响。
Pharmacology. 2008;81(2):92-6. doi: 10.1159/000109982. Epub 2007 Oct 19.
7
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.蛋白酶抑制剂洛匹那韦-利托那韦可能会使接受美沙酮维持治疗的患者出现阿片类戒断症状。
Clin Infect Dis. 2003 Aug 15;37(4):476-82. doi: 10.1086/376907. Epub 2003 Aug 1.
8
Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases.丙戊酸与其他抗惊厥药不同,对美沙酮代谢无影响:两例病例报告
J Clin Psychiatry. 1989 Jun;50(6):228-9.
9
Early recurrence of withdrawal symptoms under phenytoin and chronic alcohol use.苯妥英钠和长期饮酒情况下戒断症状的早期复发。
Pharmacopsychiatry. 1997 Mar;30(2):72-3. doi: 10.1055/s-2007-979486.
10
Depression during methadone withdrawal: no role for beta-phenylethylamine.美沙酮戒断期间的抑郁:β-苯乙胺无作用。
Drug Alcohol Depend. 1984 Jan;13(1):21-9. doi: 10.1016/0376-8716(84)90029-2.

引用本文的文献

1
Genetic Vulnerability to Opioid Addiction.遗传易感性与阿片类药物成瘾。
Cold Spring Harb Perspect Med. 2021 Jun 1;11(6):a039735. doi: 10.1101/cshperspect.a039735.
2
Pharmacotherapy in the treatment of addiction: methadone.药物治疗成瘾:美沙酮。
J Addict Dis. 2010 Apr;29(2):200-16. doi: 10.1080/10550881003684798.
3
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.ABCB1(多药耐药基因1)基因变异与有效治疗海洛因依赖所需的美沙酮剂量相关。
Hum Mol Genet. 2008 Jul 15;17(14):2219-27. doi: 10.1093/hmg/ddn122. Epub 2008 Apr 17.
4
Interindividual variability of methadone response: impact of genetic polymorphism.美沙酮反应的个体间差异:基因多态性的影响
Mol Diagn Ther. 2008;12(2):109-24. doi: 10.1007/BF03256276.
5
[Not Available].[无可用内容]。
Schmerz. 1989 Sep;3(3):155-65. doi: 10.1007/BF02527398.
6
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.美沙酮临床药代动力学的个体间变异性:对阿片类药物依赖治疗的影响。
Clin Pharmacokinet. 2002;41(14):1153-93. doi: 10.2165/00003088-200241140-00003.
7
The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.接受非核苷类逆转录酶抑制剂依非韦伦治疗的HIV阳性患者体内美沙酮的药代动力学。
Br J Clin Pharmacol. 2001 Mar;51(3):213-7. doi: 10.1046/j.1365-2125.2001.00342.x.
8
Use of methadone.美沙酮的使用。
West J Med. 2000 Jan;172(1):43-6. doi: 10.1136/ewjm.172.1.43.
9
Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.人肝微粒体中美沙酮的N-去甲基化:缺乏立体选择性及细胞色素P450 3A4的参与
Br J Clin Pharmacol. 1999 Apr;47(4):403-12. doi: 10.1046/j.1365-2125.1999.00921.x.
10
Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.镇静剂和镇痛药在治疗躁动危重症患者中的药代动力学和药效学
Clin Pharmacokinet. 1997 Dec;33(6):426-53. doi: 10.2165/00003088-199733060-00003.